1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > World Generic Markets 16 FEBRUARY 2015

World Generic Markets 16 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device Markets
Industry Brief - Intellipharmaceutics Enters Generic Drug Agreement With Teva
Industry Trend Analysis - As Biosimilar Adalimumab Progresses, Amgen And AbbVie's Fortunes Cast In Comparative Light
Industry Trend Analysis - State Biosimilar Legislation Continues To Divide; Language Will Determine Commercial Success
Industry Brief - Lupin Gains US Vancomycin Approval
Industry Brief - Orexo Files Fentanyl Patent Litigation Against Actavis
Industry Trend Analysis - US Generic Sorafenib Revenues Will Be Small, But Global Prospects Are Attractive
Industry Trend Analysis - Hospira Eyes Up Lucentis Biosimilar In Deal That Will Threaten Roche/Novartis
Industry Brief - GE Capital Provides Term Loan Financing With Amneal
Industry Brief - Vogelxo Receives AB-Rating To Testim
Industry Brief - Breckenridge Initiates Cabazitaxel Patent Challenge
Industry Brief - Oncobiologics' Adalimumab Biosimilar Meets Primary Endpoint
Industry Trend Analysis - FDA Budget Request Signals Reopening Of Labelling Debate
Industry Brief - Gedeon Richter Enters Contraceptive Patch Agreement With Bayer
Industry Brief - Actavis Launches Aripiprazole In UK
Industry Brief - Teva UK Launches Memantine
Industry Brief - Julphar Acquires Majority Stake In RAK Pharmaceuticals
Industry Brief - Beximco Passes FDA Inspection
Industry Brief - Mylan To Acquire Famy Care

Table Of Contents

World Generic Markets 16 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15900
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $24,500.  DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the global cance ...

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.